These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29559524)

  • 21. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS.
    Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C
    J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
    Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
    Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of selected synthetic cannabinoids and their metabolites by micellar electrokinetic chromatography--mass spectrometry employing perfluoroheptanoic acid-based micellar phase.
    Švidrnoch M; Přibylka A; Maier V
    Talanta; 2016 Apr; 150():568-76. PubMed ID: 26838444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-linked immunosorbent assay (ELISA) for the detection of use of the synthetic cannabinoid agonists UR-144 and XLR-11 in human urine.
    Mohr AL; Ofsa B; Keil AM; Simon JR; McMullin M; Logan BK
    J Anal Toxicol; 2014 Sep; 38(7):427-31. PubMed ID: 24908262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine.
    Kronstrand R; Brinkhagen L; Birath-Karlsson C; Roman M; Josefsson M
    Anal Bioanal Chem; 2014 Jun; 406(15):3599-609. PubMed ID: 24424965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection.
    Carlier J; Diao X; Huestis MA
    J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    Drug Test Anal; 2018 Apr; 10(4):644-650. PubMed ID: 28967189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.
    Castaneto MS; Wohlfarth A; Desrosiers NA; Hartman RL; Gorelick DA; Huestis MA
    Drug Metab Rev; 2015 May; 47(2):124-74. PubMed ID: 25853390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samples.
    Nash C; Glowacki L; Gerostamoulos D; Pigou P; Scott T; Kostakis C
    Drug Test Anal; 2019 Oct; 11(10):1480-1485. PubMed ID: 31479592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry.
    Adamowicz P; Tokarczyk B
    Drug Test Anal; 2016 Jul; 8(7):652-67. PubMed ID: 25976069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoids assessment in plasma and urine by high performance liquid chromatography-tandem mass spectrometry after molecularly imprinted polymer microsolid-phase extraction.
    Sánchez-González J; Salgueiro-Fernández R; Cabarcos P; Bermejo AM; Bermejo-Barrera P; Moreda-Piñeiro A
    Anal Bioanal Chem; 2017 Feb; 409(5):1207-1220. PubMed ID: 27815614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid quantitative method for the analysis of synthetic cannabinoids by liquid chromatography-tandem mass spectrometry.
    Freijo TD; Harris SE; Kala SV
    J Anal Toxicol; 2014 Oct; 38(8):466-78. PubMed ID: 25217534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral fluid analysis to monitor recent exposure to synthetic cannabinoids in a high-risk subpopulation.
    Pascali JP; Dagoli S; Antonioni M; Facetti O; Anzillotti L; Calò L; Affini GF; Cantarelli B; Cecchi R
    J Forensic Sci; 2022 Sep; 67(5):1932-1937. PubMed ID: 35642776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Freeze-thaw stability and long-term stability of 84 synthetic cannabinoids in serum.
    Hess C; Krueger L; Unger M; Madea B
    Drug Test Anal; 2017 Oct; 9(10):1506-1511. PubMed ID: 27863089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fast liquid chromatography/tandem mass spectrometry determination of cannabinoids in micro volume blood samples after dabsyl derivatization.
    Lacroix C; Saussereau E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():85-95. PubMed ID: 22921635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for synthetic cannabinoids in hair by using LC-QTOF MS: a new and powerful approach to study the penetration of these new psychoactive substances in the population.
    Gottardo R; Sorio D; Musile G; Trapani E; Seri C; Serpelloni G; Tagliaro F
    Med Sci Law; 2014 Jan; 54(1):22-7. PubMed ID: 23842479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of XLR-11 and its metabolites in hair by liquid chromatography-tandem mass spectrometry.
    Park M; Yeon S; Lee J; In S
    J Pharm Biomed Anal; 2015 Oct; 114():184-9. PubMed ID: 26070160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum Samples.
    Janssens LK; Boeckaerts D; Hudson S; Morozova D; Cannaert A; Wood DM; Wolfe C; De Baets B; Stock M; Dargan PI; Stove CP
    Clin Chem; 2022 Jul; 68(7):906-916. PubMed ID: 35266984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts.
    Grauwiler SB; Scholer A; Drewe J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):515-22. PubMed ID: 17236827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.